Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 07, 2016 08:02 ET | Source: DiamiR Biosciences Corp.

DiamiR Announces Formation of Advisory Board

MONMOUTH JUNCTION, NJ--(Marketwired - January 07, 2016) - DiamiR Biosciences, a developer of innovative minimally invasive diagnostic tests for early detection and monitoring of neurodegenerative...
March 16, 2015 08:02 ET | Source: DiamiR

DiamiR Announces $1.5M SBIR Phase II Funding for Further Evaluation of the microRNA Biomarkers for Early Detection of Alzheimer's Disease

MONMOUTH JUNCTION, NJ--(Marketwired - March 16, 2015) - DiamiR, LLC, a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today that the National Institute...
November 17, 2014 08:02 ET | Source: DiamiR Biosciences Corp.

DiamiR Announces Poster Presentation at the Clinical Trials on Alzheimer's Disease 2014

MONMOUTH JUNCTION, NJ--(Marketwired - November 17, 2014) - DiamiR Biosciences, a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today that the company's...
July 10, 2014 08:02 ET | Source: DiamiR LLC

DiamiR Announces Oral Presentation at the 2014 Alzheimer's Association International Conference

MONMOUTH JUNCTION, NJ--(Marketwired - July 10, 2014) - DiamiR, LLC, a molecular diagnostics company focused on the development and commercialization of innovative tests for detection and monitoring...
April 28, 2014 08:00 ET | Source: DiamiR LLC

DiamiR Announces Poster Presentation on Detection and Differentiation of Neurodegenerative Diseases at the Biomarkers & Diagnostics World Congress 2014

MONMOUTH JUNCTION, NJ--(Marketwired - April 28, 2014) - DiamiR, LLC, a molecular diagnostics company focused on the development and commercialization of innovative blood-based...
January 02, 2014 04:00 ET | Source: DiamiR LLC

DiamiR Reports Validation of Two Families of Brain-Enriched microRNAs as Highly Promising Blood-Based Biomarkers of Mild Cognitive Impairment

MONMOUTH JUNCTION, NJ--(Marketwired - January 02, 2014) - DiamiR, LLC, a molecular diagnostics company focused on the development and commercialization of innovative blood-based...